RECODID is a multi-country, four-year project that began in January, 2019. The project is coordinated by Heidelberg University Hospital (UKHD, Dr Thomas Jaenisch) in Germany and brings together 13 complementary partners to address some of the most pressing issues in the development of personalized medicine approaches to infectious disease with a focus on the global response to emerging pathogens.
The RECODID initiative is supported by the European Commission under the Horizon 2020 Programme.
A MULTIDISCIPLINARY, INTERNATIONAL COLLABORATIVE NETWORK
EUROPE
Germany
Heidelberg University Hospital – UKHD (Coordinator): Thomas Jaenisch
The Netherlands
Erasmus University Medical Center – EMC: Marion Koopmans
France
Aix-Marseille University – AMU: Xavier de Lamballerie
Germany
EMBL European Bioinformatics Institute – EMBL-EBI: Guy Cochrane
The Netherlands
University Medical Centre Utrecht – UMC Utrecht: Thomas Debray
Denmark
Technical University of Denmark – DTU: Peter Longreen
NORTH AMERICA
Canada
McMaster University – MCMASTER: Claudia Emerson
Canada
University of British Columbia – UBC: Paul Gustafson
Canada
McGill University – MCGILL: Guillaume Bourque
USA
University of California Berkeley – UBC: Eva Harris
Canada
The Research Institute of the McGill University Health Centre (RI MUHC) – Montreal General Hospital
USA
University of Colorado Anschutz Medical Campus – UC : Thomas Jaenisch
SOUTH & CENTRAL AMERICA
Colombia
Universidad Industrial de Santander – UIS: Luis Villar
Nicaragua
Sustainable Sciences Institute – SSI: Angel Balmaseda
AFRICA
Senegal
Institut Pasteur de Dakar – IPD: Amadou Sall
